SPOT Radio
Welcome to Sterile Device Packaging on Track podcast. Listen in as we speak with the nation’s leading experts in medical device packaging.The goal of this Podcast is to engender a community of packaging and manufacturing engineers that can pose questions to our panel of SME’s. We will cover all corners of medical device packaging from trending medical device packaging regulatory issues, new packaging technologies, and techniques as well as a host of case studies designed to make your medical device packaging program more robust.We would love to hear your feedback about our program and receive your input and suggestions on how we may improve this podcast. We are working to build a community of enlightened medical device packaging professionals. If you would like to be included in an upcoming episode please feel free to contact us at our website - www.spotradiopodcast.com, or send us an email to info@spotradiopodcast.com.
SPOT Radio
Exploring the future of at-home diagnostics testing systems
On this episode of SPOT radio, Charlie Webb has an edifying conversation with Jeremy Stackawitz from Senzo about the future of at-home diagnostics systems. As this new market grows in healthcare it is a great time to ponder how medical device packaging will support this new end-point. This new paradigm will surely launch new growth for medical device and diagnostic packaging machines and material providers.
About Jeremy Stackawitz:
Jeremy holds a science degree from Dartmouth and earned his MBA in Healthcare management from Wharton. He has 25+ years in healthcare with 15 of those years in diagnostics. At present Jeremy is CEO of Senzo, he resides in Pennsylvania with his wife and 3 kids and loves bringing innovative products to market.
About Senzo:
Senzo, is a leading in vitro diagnostics company, that recently announced the successful development, and completion of a new 7-minute Covid-19 lateral flow rapid antigen Self-Test with the same accuracy as professional laboratory PCR tests, the industry’s gold standard. In an operator-blind study of 59 positive and 101 negative Covid-19 test samples, across all major variants, the Senzo Amplified Lateral Flow (ALF) test achieved 98.3% positive percent agreement (PPA) and 99.0% negative percent agreement (NPA) with PCR results, and 100.0% positive percent agreement (PPA) for samples with a Ct value between 33 - 38, representing very low levels of target nucleic acid in the sample.
LinkedIn:
https://www.linkedin.com/in/jeremystackawitz/
Websites:
http://www.senzo.com
https://www.emdevicelab.com
E-mail:
Jeremy@senzo.com